These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Release of enzymes from a rat liver lysosome fraction: inhibition by catecholamines and cyclic3', 5'-adenosine monophosphate, stimulation by cholinergic agents and cyclic 3', 5'-guanosine monophosphate. Ignarro LJ, Krassikoff N, Slywka J. J Pharmacol Exp Ther; 1973 Jul; 186(1):86-99. PubMed ID: 4353102 [No Abstract] [Full Text] [Related]
8. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. Rivkin I, Rosenblatt J, Becker EL. J Immunol; 1975 Oct; 115(4):1126-34. PubMed ID: 170335 [Abstract] [Full Text] [Related]
9. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes. Stephens CG, Snyderman R. J Immunol; 1982 Mar; 128(3):1192-7. PubMed ID: 6120193 [Abstract] [Full Text] [Related]
10. Effects of pharmacologic agents on release of lysosomal enzymes from alveolar mononuclear cells. Ackerman NR, Beebe JR. J Pharmacol Exp Ther; 1975 May; 193(2):603-13. PubMed ID: 167151 [Abstract] [Full Text] [Related]
11. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems. Moake JL, Cimo PL, Widmer K, Peterson DM, Gum JR. Thromb Haemost; 1977 Aug 31; 38(2):420-8. PubMed ID: 202038 [Abstract] [Full Text] [Related]
12. Genetic control of ligand-induced events in B lymphocytes. Fram RJ, Sidman CL, Unanue ER. J Immunol; 1976 Nov 31; 117(5 Pt 1):1456-63. PubMed ID: 794411 [Abstract] [Full Text] [Related]
13. Refractoriness to muscarinic and adrenergic agonists in the rat parotid: responses of adenosine and guanosine cyclic 3', 5'-monophosphates. Harper JF, Brooker G. Mol Pharmacol; 1977 Nov 31; 13(6):1048-59. PubMed ID: 201829 [No Abstract] [Full Text] [Related]
14. Regulation of antibody response in vitro. X. Biphasic effect of cyclic AMP on the secondary anti-hapten antibody response to anti-immunoglobulin and enhancing soluble factor. Kishimoto T, Ishizaka K. J Immunol; 1976 Feb 31; 116(2):534-41. PubMed ID: 175119 [Abstract] [Full Text] [Related]
15. Modulation of human T lymphocyte rosette formation by autonomic agonists and cyclic nucleotides. Grieco MH, Siegel I, Goel Z. J Allergy Clin Immunol; 1976 Jul 31; 58(1 PT. 2):149-59. PubMed ID: 182731 [Abstract] [Full Text] [Related]
16. Regulation of intracellular cyclic GMP and cyclic AMP levels in mouse lung fragments by disodium cromoglycate, beta-adrenergic agonists, cholinergic activators, and histamine. Moore JB. Res Commun Chem Pathol Pharmacol; 1977 Aug 31; 17(4):639-47. PubMed ID: 19825 [Abstract] [Full Text] [Related]
17. [Cyclic nucleotides and calcium ions in the activation of B-lymphocyte movement in mice by an anti-immunoglobulin serum]. Ado AD, Dontsov VI. Biull Eksp Biol Med; 1984 Dec 31; 98(12):692-4. PubMed ID: 6334538 [Abstract] [Full Text] [Related]
18. In vitro immune response of human peripheral lymphocytes. III. Effect of anti-mu or anti-delta antibody on PWM-induced increase of cyclic nucleotides in human B lymphocytes. Ohara J, Kishimoto T, Yamamura Y. J Immunol; 1978 Nov 31; 121(5):2088-96. PubMed ID: 213490 [Abstract] [Full Text] [Related]
19. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. Melmon KL, Bourne HR, Weinstein Y, Shearer GM, Kram J, Bauminger S. J Clin Invest; 1974 Jan 31; 53(1):13-21. PubMed ID: 4357609 [Abstract] [Full Text] [Related]
20. Colchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions. Jasper JR, Post SR, Desai KH, Insel PA, Bernstein D. J Pharmacol Exp Ther; 1995 Aug 31; 274(2):937-42. PubMed ID: 7636757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]